arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ginkgo Bioworks Holdings, Inc.

DNA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.22
▼ -9.2% Today
as of Jun 7, 07:13 ET
Last 30 days +4.71% Apr 28 → Jun 05
$7.12 $7.98 $8.84 $9.70 $10.56 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$8.90
High
$8.98
Low
$7.94
Volume
$1M
Avg Vol
$1M
Mkt Cap
$588M
P/E (TTM)
Beta
52w High
$17.58
52w Low
$5.37
Div Yield
Shares Out
$62M

Overview

52-week range
$5.37
$18
23% of range
Avg surprise (last 1)
-28.5%
Avg reaction (last 2)
-2.2%
50% positive
Latest IV / EM
132%
EM ±18.2% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.21$-4.68$-3.15$-1.62$-0.09 Actual $-0.09Actual $-6.21Actual $-3.32Actual $-4.23Actual $-1.08Actual $-1.58Est $-1.23Actual $-1.10Actual $-1.45Actual $-1.28 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-217M$-140M$-62M$16M$93M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.28 +19.0% +2.4% earnings
Tue Sep 30, 2025Sep 2025 $-1.45 financials
Mon Jun 30, 2025Jun 2025 $-1.10 financials
Tue May 6, 2025Mar/2025 $-1.58 $-1.23 -28.5% -6.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.08 financials
Sun Jun 30, 2024Jun 2024 $-4.23 financials
Sun Mar 31, 2024Mar 2024 $-3.32 financials
Sat Sep 30, 2023Sep 2023 $-6.21 financials
Fri Jun 30, 2023Jun 2023 $-0.09 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$19M$39M$50M$38M$89M$56M
Cost of revenue$3M$4M
Gross profit
Operating income$-71M$-90M$-66M$-81M$-55M$-223M
Net income$-83M$-81M$-91M$-56M$-217M
EPS (diluted)$-1.45$-1.10$-1.68$-1.08$-4.23

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$144M$167M$111M$204M$312M$562M$616M$730M
Inventory
Total current assets$410M$472M$506M$523M$565M$603M$662M$783M
Total assets$1.03B$1.12B$1.19B$1.23B$1.29B$1.38B$1.48B$1.63B
Long-term debt
Total liabilities$590M$611M$629M$618M$646M$661M$683M$792M
Total equity$443M$509M$560M$613M$647M$716M$798M$833M

Implied volatility — last 90 days

126%129%131%134%136% Jun 07 — IV 132% · EM ±18.2%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.